Dr. Harshabad (Harsh) Singh, MBBS, MD, is a medical oncologist and physician-scientist specializing in pancreatic and hepatobiliary cancers. He serves as Program Director for Hepatobiliary and Pancreas Oncology at the MGB Cancer Institute, where his work bridges clinical innovation and translational research. Dr. Singh's is a translational scientist who focuses on developing novel therapeutic strategies and biomarkers for pancreatic cancer to improve early detection and treatment response prediction. He is committed to building a collaborative, patient-centered program that advances discovery and care for individuals with HPB malignancies.